Newsletter - December 2017

Greeting words from neuroCare founder Thomas Mechtersheimer - our achievements in 2017 / new clinics in the Netherlands, USA, Australia / Research Highlights in 2017 / neuroCademy and neuroConn milestones

Newsletter - October 2017

rTMS in the treatment of depression and OCD: Dutch health insurance companies reimburse rTMS treatment
for treatment resistant depression / OCD: Sleep could play a role in outcome of rTMS treatment / neuroCare provides rTMS technology; Accurate and reliable EEG measurement during transcranial alternating current stimulation (tACS) - a first step towards closedloop systems is done; tDCS and neuroplasticity: stroke and working memory; Upcoming conferences and workshops

Read the October edition in Spanish

rTMS para el tratamiento de la depresión y las compulsiones: Los seguros de salud holandeses reembolsan los costes del tratamiento con rTMS en los casos de depresiones resistentes a la terapia / Compulsiones: El sueño podría ser decisivo sobre el éxito del tratamiento con rTMS / La tecnología rTMS en neuroCare; Realización exacta y fiable del EEG durante la estimulación transcraneal con corriente alterna (tACS) – Se ha dado un primer paso.; tDCS y neuroplasticidad: ictus, memoria de trabajo; Próximas conferencias, cursos y talleres de formación

Read the October edition in French

La rTMS pour le traitement de la dépression et des troubles obsessionnels compulsifs : Les caisses d'assurance maladie néerlandaises remboursent les frais du traitement par rTMS dans les cas de dépression résistante aux traitements / Troubles obsessionnels compulsifs : le sommeil peut déterminer le succès du traitement par rTMS / La technologie de la rTMS chez neuroCare ; Mesure exacte et précise des EEG pendant la stimulation transcrânienne par courant alternatif (tACS) : une première étape est franchie ; Stimulation transcrânienne à courant direct (tDCS) et neuroplasticité : accident vasculaire cérébral, mémoire de travail ; Conférences, ateliers et cours de formation

Science Newsletter - June 2017

Consensus paper on transcranial Electric Stimulation published; Successful installation of neuroConn's DC-STIMULATOR MC at the Department of Psychology at the University of Bern; Technical Improvements of neuroConn’s stimulator devices for tES-EEG (DC-STIMULATOR PLUS and DC-STIMULATOR MC); neuroConn's first demo of closed-loop tACS-EEG; Phase coupling and uncoupling with tACS; upcoming conferences and neuroCademy workshops

Newsletter - April 2017

SCP Neurofeedback now considered more than just "placebo"; tDCS receives Level B recommendation as treatment for Depression; DC-STIMULATOR MOBILE for transcranial stimulation in routine clinical practice; Progress of neuroCare clinics worldwide; New cutting edge technology by neuroCare; Meet Peter Obstoj - Managing Director (Operations) neuroConn.

Read the April edition in French

Le neurofeedback est bien plus qu'un simple « placebo »; La tDCS (stimulation transcrânienne à courant direct) a obtenu la recommandation de catégorie B pour la prise en charge de la dépression; DC-STIMULATOR MOBILE pour la stimulation transcrânienne à courant direct dans la pratique clinique; Avancées dans les centres de traitement neuroCare; Les dernières technologies appliquées à la tES (électrostimulation transcrânienne); Entretien avec Peter Obstoj - Directeur de la production de neuroConn

Read the April edition in Spanish

El neurofeedback es algo más que un placebo; La ETCD obtiene una recomendación de tipo B para el tratamiento de la depresión; DC-STIMULATOR MOBILE para la estimulación transcraneal por corriente directa en aplicación clínica; neuroCare – Conferencias y ferias; neuroCademy – Talleres y cursos de formación; Avances en los centros de tratamiento neuroCare; La última versión tecnológica de la ETC; Entrevista con Peter Obstoj – Director de Producción de neuroConn

Newsletter - November 2016

Introducing Dr. Eliana García Cossio and Annika Simlaker; tDCS devices have new intended use in therapy; new electrodes in application of tDCS; Brainsight TMS updates; ActTrust actigraphy watches; NIBS now multimodal; Neuro-Cardiac-Guided TMS; nC-Explorer software update; latest in research for Neurofeedback in ADHD

Newsletter - August 2015

neuroConn now neuroCare Group

tDCS and Effectiveness; Seeing Better with Alternating Current; Depression: tDCS improves processing of negative emotions; Sleep quality improves through Neurofeedback; Neurofeedback improves control over impulsive and aggressive behavior in psychopaths

Newsletter - February 2015

New approval for DC-STIMULATOR in Korea; Safety of ADHD medications for children

tDCS in depression: current state of research; New fields of research on tDCS; German Center for Brain Stimulation in Psychiatry (GCBS); tDCS only with medical supercision and with certified medical devices

SCP training sustainable in the treatment of Epilepsy; Neurofeedback and NIRS for ADHD; Brain research in forensic psychiatry

Newsletter - April 2014

We have moved. More space in a more modern environment; DC-STIMULATOR PLUS: new registrations; International, national and regional research projects with our participation

Overview of research projects with neuroCare participation; tDCS can help patients regain state of consciosness after coma; Shaping memory accuracy by tDCS; Amount of consumed medication decreased slightly

Newsletter - February 2014

neuroConn moved to new premisses

Future of neuromodulatoin: mobile tDCS; Neurofeedback for ADHD: State of research; Brain stimulatoin affects compliance with social norms; tDCS helps to quit smoking; Post-stroke rehabilitation with tDCS

Newsletter - May 2013

Neurofeedback training of SCP in adults; Meta-analysis on the efficacy of non-pharmaceutical interventions for ADHD in the child and adolescent psychiatry; Neurofeedback for the therapy of Parkinson's disease?; Neurofeedback of local brain activity; Neurofeedback in forensic science; Transcranial brain stimulation - German Society of Child and Adolescent Psychiatry, Psychosomatic and Psychotherapy (DGKJP); Neurofeedback in professional sports

Newsletter - September 2012

New Generation of the DC-STIMULATOR PLUS with explanations of the product innovations

tACS-EEG of growing interest in research; Latest research with DC-STIMULATOR presented at CNS 2012

Newsletter - February 2012

Announcement of the new generation of the DC-STIMULATOR PLUS; Targeted transcranial HD-Stimulation; Societal impact of pain - EFIC Congress 2011; tDCS shows promising results in latest psychiatric and neurological research

Neurofeedback for ADHD; THERA PRAX®: preferential device for studies and therapy of ADHD

Sign-Up for the Newsletter

Receive regular updates on the latest in neuromoodulation technologies, training and clinics by subscribing to our online newsletter below.

With this registration you will receive the neuroCare newsletter directly to your inbox.

You may unsubscribe from the newsletter at any time by writing to


Once you have registered you will receive a confirmation by e-mail.